<DOC>
	<DOCNO>NCT00325169</DOCNO>
	<brief_summary>This study design evaluate effect lung function combination SERETIDE 50/500mcg twice daily plus tiotropium bromide 18mcg daily compare individual treatment ( tiotropium bromide 18mcg daily alone SERETIDE 50/500mcg twice daily alone ) subject COPD . The study utilise three-way cross-over design 2-week wash-out period 2-week consecutive treatment period .</brief_summary>
	<brief_title>SERETIDE Plus Tiotropium Versus Individual Components</brief_title>
	<detailed_description>A randomised , double-blind , double dummy , 3 way cross-over study evaluate effect SERETIDEâ„¢ 50/500mcg twice daily plus tiotropium bromide 18mcg daily compare individual treatment ( tiotropium bromide 18mcg alone SERETIDE 50/500mcg alone ) treatment subject COPD</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Has establish clinical history COPD define per GOLD definition . Postbronchodilator FEV1 &gt; 30 % 75 % predict normal Visit 1 , postbronchodilator FEV1 / FVC ratio = 70 % . Current exsmoker smoke history &gt; 10 packyears . Has unstable COPD ( Chronic Obstructive Pulmonary Disease ) . Has current medical diagnosis asthma and/or allergic rhinitis know respiratory disorder ( lung cancer , sarcoidosis , tuberculosis lung fibrosis ) Requires regular ( daily ) long term oxygen therapy ( LTOT ) . ( LTOT define &gt; 12 hour oxygen use per day ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cross-over</keyword>
	<keyword>Tiotropium</keyword>
	<keyword>Triple</keyword>
	<keyword>COPD</keyword>
	<keyword>SERETIDE 50/500</keyword>
	<keyword>Dyspnoea</keyword>
	<keyword>Impulse oscillometry</keyword>
	<keyword>Plethysmography</keyword>
</DOC>